Grace Niewijk

White paper for Curia Global (commissioned via C&EN) describing the benefits of strategic NIH programs that bring together government, academic, and industry resources to accelerate drug discovery and help potential treatments escape the "valley of death."

Article for University of Chicago Medicine

A new analysis from UChicago Medicine researchers shows that people who experienced their parents being incarcerated while they were under the age of 18 were at higher risk of cardiovascular issues as young adults.

Article for University of Chicago Medicine

A research team supervised by a health policy researcher at the University of Chicago has found that increasingly common private equity investments in healthcare are generally associated with higher costs to patients and payers.

eBook for C&EN BrandLab commissioned by MilliporeSigma

This resource provides a technical yet accessible overview of chemical proximity labeling techniques for investigating protein interactions, both for basic science investigation and pharmaceutical research.

Article for Chemical & Engineering News sponsored by Genentech

Annual workshop empowers chemists from underrepresented groups to thrive in diverse careers.

Article for Metabolic Insights, the blog of Levels Health

Inositol has recently gained attention as a potential treatment for polycystic ovarian syndrome (PCOS). Inositol is a naturally occurring molecule that can be taken as a supplement and has been the subject of multiple studies and randomized controlled trials as a remedy for PCOS. This blog covers some of the most important research findings—what inositol is, why people are considering it, how it works, and whether it might be a viable treatment option for PCOS.

Article for Chemical & Engineering News BrandLab sponsored by Pfizer

Specific pressures and power structures in STEM fields create unique challenges and considerations for helping LGBTQ+ people succeed and thrive. This article explores strategies for supporting inclusion in chemistry at Pfizer and beyond.

eBook for Vizgen

Like detective work, detailed understanding of the complexities of biological systems requires scientists to answer questions about details at every level: what, when, why, how…and where. This eBook helps establish data quality metrics for the nascent field of spatial transcriptomics and gives researchers the information they need to compare spatial technology platforms.

eBook for Bio-Rad Laboratories

This eBook explores how cutting-edge technology is enabling more precise, timely care for solid tumor cancers. Compare and contrast ultra-sensitive molecular methods such as NGS and ddPCR technology that are already driving advancements in therapy monitoring and minimal residual disease (MRD) testing for solid tumors.

Article written for Discovery Life Sciences

With a potential recession on the horizon, biotechnology companies are seeing funding sources drying up. Large and small organisations alike must find creative ways to leverage their assets and opportunities to continue moving forward. Partnering with biopharmaceutical outsourcing companies gives drug and diagnostic developers the ability to apply advanced tools for drug discovery, analysis and quality control without making capital investments they cannot afford.

Blog post for Bio-Rad Laboratories

Cancer remains a leading cause of death worldwide. However, as cancer treatments continue to improve and diagnoses happen sooner, more and more patients are experiencing remission. To further increase survival rates and reduce unnecessary treatment, scientists and clinicians are turning to ultra-sensitive molecular analysis to inform treatment decisions and predict and detect relapse.

Whitepaper for The Jackson Laboratory

To avoid risks and setbacks associated with CAR T therapies, scientists need a preclinical research platform that will deliver fast, reproducible, relevant, and actionable results without endangering human patients. A humanized in vivo platform is ideal for CAR T cell therapy characterization, safety, and efficacy testing.

Case study for Amazon Web Services (AWS).

To help biopharma and biotechnology companies streamline and accelerate their drug discovery and development pipelines, Insilico Medicine developed a robust suite of machine learning (ML)-powered tools to aid in target identification, molecule design, and lead optimization.

Article for American Pharmaceutical Review on behalf of The Jackson Laboratory

Engrafting human immune systems into mice yields a versatile preclinical platform for generating reproducible, translationally-relevant data about the safety and efficacy of novel therapeutics. With this tool, scientists can evaluate CRS risk, perform dose ranging studies, and observe downstream organ effects of immune responses in a diversified population, giving better predictions of clinical outcomes.

Article for The Jackson Laboratory

The Jackson Laboratory (JAX) has developed a versatile toolset of mouse models capable of supporting extensive functional components of the human immune system. These mice provide a preclinical research platform that yields sensitive, reproducible results to screen drug candidates for inflammatory responses. The platform also offers insight into the progression of immune disorders and the potential efficacy of drugs meant to treat them.